NeuroPace (NPCE) FCF Margin Growth (1y) (2021 - 2026)
Powered by 
Analysis
NeuroPace (NPCE) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 194.00 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 984.00 |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 641.00 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 66.00 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 119.00 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 1,788.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -177.00 |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -395.00 |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -473.00 |
| 10 | NeuroPace | 493.15 Mn | 441.45 Mn | 18.91 Mn | -655.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -655.00 |
| Mar 31, 2026 | 666.00 |
| Dec 31, 2025 | 2,384.00 |
| Sep 30, 2025 | 179.00 |
| Jun 30, 2025 | 948.00 |
| Mar 31, 2025 | 819.00 |
| Dec 31, 2024 | -380.00 |
| Sep 30, 2024 | 517.00 |
| Jun 30, 2024 | 607.00 |
| Mar 31, 2024 | 2,583.00 |
| Dec 31, 2023 | 4,386.00 |
| Sep 30, 2023 | 4,830.00 |
| Jun 30, 2023 | 7,986.00 |
| Mar 31, 2023 | 3,498.00 |
| Dec 31, 2022 | 1,360.00 |
| Sep 30, 2022 | -1,808.00 |
| Jun 30, 2022 | -5,836.00 |
| Mar 31, 2022 | -4,969.00 |
| Dec 31, 2021 | -1,593.00 |
| Sep 30, 2021 | -200.00 |